908 Devices (MASS) Expected to Post Quarterly Earnings on Tuesday

908 Devices (NASDAQ:MASS) is expected to post its Q2 2026 results before the market opens on Tuesday, August 4th. Analysts expect the company to announce earnings of ($0.14) per share and revenue of $15.4180 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 8:30 AM ET.

908 Devices Price Performance

Shares of MASS stock opened at $7.13 on Tuesday. The business has a fifty day moving average of $8.13 and a 200 day moving average of $7.13. The firm has a market capitalization of $269.61 million, a price-to-earnings ratio of -7.13 and a beta of 0.63. 908 Devices has a 1 year low of $5.03 and a 1 year high of $9.34.

Wall Street Analyst Weigh In

MASS has been the subject of a number of research reports. Weiss Ratings downgraded shares of 908 Devices from a “hold (c-)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. Wall Street Zen cut shares of 908 Devices from a “buy” rating to a “hold” rating in a research note on Saturday, July 18th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, 908 Devices presently has a consensus rating of “Hold” and an average target price of $12.00.

Insider Activity at 908 Devices

In other 908 Devices news, SVP John Kenneweg sold 7,787 shares of the company’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $6.83, for a total transaction of $53,185.21. Following the completion of the transaction, the senior vice president directly owned 76,039 shares in the company, valued at approximately $519,346.37. This represents a 9.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Christopher D. Brown sold 9,900 shares of the company’s stock in a transaction on Tuesday, June 23rd. The stock was sold at an average price of $9.04, for a total transaction of $89,496.00. Following the transaction, the director owned 865,559 shares of the company’s stock, valued at $7,824,653.36. This represents a 1.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 96,927 shares of company stock valued at $815,293. 28.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. IQ EQ FUND MANAGEMENT IRELAND Ltd lifted its stake in 908 Devices by 47.8% in the 4th quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 78,026 shares of the company’s stock valued at $410,000 after buying an additional 25,239 shares in the last quarter. American Century Companies Inc. increased its stake in 908 Devices by 22.9% during the 2nd quarter. American Century Companies Inc. now owns 56,296 shares of the company’s stock worth $401,000 after buying an additional 10,482 shares in the last quarter. AQR Capital Management LLC purchased a new stake in 908 Devices during the 1st quarter worth approximately $365,000. Jane Street Group LLC acquired a new position in shares of 908 Devices during the second quarter valued at approximately $341,000. Finally, Wells Fargo & Company MN raised its holdings in shares of 908 Devices by 72.1% during the fourth quarter. Wells Fargo & Company MN now owns 30,623 shares of the company’s stock valued at $161,000 after acquiring an additional 12,828 shares during the last quarter. Institutional investors and hedge funds own 88.06% of the company’s stock.

About 908 Devices

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.